Page last updated: 2024-11-05

pamabrom

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Pamabrom is a synthetic compound primarily used as a diuretic and anti-inflammatory agent. It is often found in over-the-counter medications for premenstrual syndrome (PMS) and menstrual cramps. Pamabrom is thought to work by inhibiting the production of prostaglandins, hormones that contribute to inflammation and pain. However, its use in PMS treatment is controversial, as its efficacy has not been conclusively proven. Pamabrom is typically taken orally and is generally considered safe for short-term use, although potential side effects include nausea, vomiting, and stomach cramps. Despite its historical use, pamabrom has been largely replaced by newer and more effective medications for PMS and menstrual cramps. Nevertheless, it remains an active area of research, with studies investigating its potential benefits in other conditions such as migraines and edema.'

Cross-References

ID SourceID
PubMed CID11806
CHEMBL ID2104825
SCHEMBL ID92712
MeSH IDM0190827

Synonyms (47)

Synonym
pamabrom
8-bromo-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compound with 2-amino-2-methyl-1-propanol (1:1)
2-amino-2-methylpropanol 8-bromotheophyllinate
8-bromotheophylline compound with 2-amino-2-methyl-1-propanol (1:1)
unii-ua8u0kjm72
pamabrom [usan:usp]
ua8u0kjm72 ,
backaid
einecs 210-103-4
pamabrom (usp)
606-04-2
D08962
8-bromo-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione compound with 2-amino-2-methylpropan-1-ol (1:1)
A832802
CHEMBL2104825
HY-17391
CS-1106
FT-0603488
pamabrom [vandf]
pamabrom [mart.]
pamabrom [mi]
pamabrom [usan]
pamabrom [who-dd]
2-amino-2-methylpropanol-1-8-bromotheophyllinate
pamabrom [usp monograph]
S5555
AKOS016339632
CCG-213575
SCHEMBL92712
KS-5228
DTXSID80209397
DB11106
606-04-2 (salt)
mfcd00867328
8-bromo-1,3-dimethyl-1h-purine-2,6(3h,7h)-dione compound with 2-amino-2-methylpropan-1-ol (1:1)
AS-11777
8-bromotheophylline 2-amino-2-methyl-1-propanol
P2359
Q7129023
2-amino-2-methylpropan-1-ol;8-bromo-1,3-dimethyl-7h-purine-2,6-dione
T72689
2-amino-2-methyl-1-propanol-8-bromotheophyllinate
8-bromo-1,3-dimethyl-3,9-dihydro-purine-2,6-dione
diurexmax
pamabrom (usp monograph)
pamabrom (mart.)
midol bloat relief

Research Excerpts

Overview

Pamabrom is a mild diuretic present in several over-the-counter and prescription menstrual symptom relievers.

ExcerptReferenceRelevance
"Pamabrom is a mild diuretic present in several over-the-counter and prescription menstrual symptom relievers."( Fixed drug eruption from pamabrom.
Camisa, C; Durkin, WJ; Helm, T; Nedorost, S; Taylor, JS; Tomecki, KJ,
)
1.16

Compound-Compound Interactions

ExcerptReferenceRelevance
" Its combination with pamabrom, a mild diuretic agent, (Women s Tylenol Menstrual Relief Caplets, Midol Teen) was approved by the FDA for use in this indication."( Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea?
De Los Santos, AR; Di Girolamo, G; González, CD; Sánchez, AJ, 2004
)
0.9
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.78 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index119.28 (26.88)
Search Engine Supply Index2.19 (0.95)

This Compound (66.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.69%)5.53%
Reviews2 (15.38%)6.00%
Case Studies4 (30.77%)4.05%
Observational0 (0.00%)0.25%
Other6 (46.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]